| Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635) |
|---|
| 04/03/2001 | US6211197 Carboxylic acid or tetrazole derivates; analgesics, antipyretics, and antiinflammatory agents; side effect reduction |
| 04/03/2001 | US6211179 Treating sexual disorders, impotency, and menopause; administering purine derivative; nitric oxide synthase substrates |
| 04/03/2001 | US6211156 Peptides for treatment of erectile dysfunction |
| 04/03/2001 | US6211152 Formulations for peptide release |
| 04/03/2001 | US6210343 Use of misoprostol or/and misoprostol acid for diagnosis of vascular damage in a subject with erectile dysfunction |
| 04/03/2001 | CA2210823C Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration |
| 03/29/2001 | WO2001022091A2 Method for determining the fertility of mammals, especially of humans |
| 03/29/2001 | WO2001021658A1 32 human secreted proteins |
| 03/29/2001 | WO2001021620A2 Amine derivatives of benzo-4,5-thieno-2,3-d pyrimidines |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 03/29/2001 | WO2001021194A2 Method for the therapeutic management of endometriosis and fallopian tube obstruction |
| 03/29/2001 | WO2001021159A2 Pharmaceutical composition of nateglinide and another antidiabetcagent |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | WO2000052148A3 Substances for controlling fertility |
| 03/29/2001 | WO2000047583A8 Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 03/29/2001 | CA2387520A1 Amine derivatives |
| 03/29/2001 | CA2385480A1 32 human secreted proteins |
| 03/29/2001 | CA2385264A1 Method for determining the fertility of mammals, especially of humans |
| 03/29/2001 | CA2383510A1 Method for the therapeutic management of extrauterine proliferation of endometreial tissue, chronic pelvic pain and fallopian tube obstruction |
| 03/28/2001 | EP1086219A2 Proteins regulating gene expression |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086096A1 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |
| 03/28/2001 | EP1085905A1 Immunotherapeutic composition and method for the treatment of prostate cancer |
| 03/28/2001 | EP1085903A1 Egg surface proteins and methods for use for modulating fertility |
| 03/28/2001 | EP1085894A1 Beta 3-adrenergic receptor agonists |
| 03/28/2001 | EP1085889A2 Novel therapeutic agents that modulate endothelin receptors |
| 03/28/2001 | EP1085887A2 Novel angiotensin receptor modulators and their uses |
| 03/28/2001 | EP1085871A1 QUINAZOLINONE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/28/2001 | EP1085870A2 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 03/28/2001 | EP1085869A1 Spiropiperidine derivatives as melanocortin receptor agonists |
| 03/28/2001 | EP1085868A1 H1-histamine receptor antagonists |
| 03/28/2001 | EP1085855A1 Enhanced intra vaginal devices |
| 03/28/2001 | EP1085847A2 Novel therapeutic agents that modulate estrogen receptors |
| 03/28/2001 | EP0775132B1 (azetidin-1-ylalkyl)lactams as tachykinin antagonists |
| 03/28/2001 | CN1289335A Azolo triazizes and pyrimidines |
| 03/28/2001 | CN1289334A Benzothiadiazoles and derivatives |
| 03/28/2001 | CN1289249A Derivatives of 1,3,4-oxadiazolone |
| 03/28/2001 | CN1288752A Menopathy treating oral liquid |
| 03/28/2001 | CN1288749A Medicated sanitary article for treating gynopathy and its preparation |
| 03/28/2001 | CN1288746A Chinese medicine for mastopathy and its preparation |
| 03/28/2001 | CN1063647C Drug compositions for preventing and treating gonorrhoae and syphilips |
| 03/27/2001 | US6207829 Cyclization of a corresponding pyrazole compound |
| 03/27/2001 | US6207690 Treating tumor by administering therapeutically effective amount of triglitazone compound |
| 03/27/2001 | US6207374 Tuberous sclerosis 2 gene and uses thereof |
| 03/27/2001 | CA2065860C Inhibiting transforming growth factor .beta. to prevent accumulation of extracellular matrix |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019817A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019802A1 Aromatic nitrogenous six-membered ring compounds |
| 03/22/2001 | WO2001019387A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | WO2001019370A1 Agents for ameliorating erectile dysfunction |
| 03/22/2001 | WO2001019369A1 Use of thienopyrimidines |
| 03/22/2001 | WO2001019361A2 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 03/22/2001 | WO2001019354A2 Composition for ivf |
| 03/22/2001 | WO2001019339A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | WO2001019338A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | WO2001008695A3 Use of amh and/or amh agonists and/or amh antagonists for long-term control of female fertility |
| 03/22/2001 | WO2001005435A3 Antisense therapy for hormone-regulated tumors |
| 03/22/2001 | WO2001000811A3 17867, a novel human aminopeptidase |
| 03/22/2001 | WO2000069255A8 Anti-inflammatory therapy for inflammatory mediated infection |
| 03/22/2001 | WO2000059899A8 Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them |
| 03/22/2001 | WO2000040612A9 Insulin-like growth factor (igf) i mutant variants |
| 03/22/2001 | WO2000029443A9 Contraceptive antibody vaccines |
| 03/22/2001 | WO1999063936A8 Novel therapeutic agents that modulate endothelin receptors |
| 03/22/2001 | DE19944604A1 Aminderivate Amine derivatives |
| 03/22/2001 | DE10036855A1 Neue kristalline Form von 6-Hydroxy-3-(4-[2-(piperidin-1-yl) ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophenhydrochlorid New crystalline form of 6-hydroxy-3- (4- [2- (piperidin-1-yl) ethoxy] phenoxy) -2- (4-methoxyphenyl) benzo [b] thiophene hydrochloride |
| 03/22/2001 | CA2387123A1 Use of thienopyrimidines |
| 03/22/2001 | CA2385769A1 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | CA2385747A1 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | CA2385065A1 Formulations for parenteral use of estramustine phosphate and sulfoalkyl ether cyclodextrins |
| 03/22/2001 | CA2385063A1 Formulations for parenteral use of estramustine phosphate with improved pharmacological properties |
| 03/22/2001 | CA2384991A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | CA2384783A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384782A1 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | CA2384324A1 Proteins associated with cell differentiation |
| 03/22/2001 | CA2382908A1 Composition for ivf |
| 03/22/2001 | CA2381252A1 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/21/2001 | EP1085089A2 Human cyclic nucleotide phosphodiesterase |
| 03/21/2001 | EP1084125A1 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action |
| 03/21/2001 | EP1084109A1 2-aminopyridines containing fused ring substituents as nitric oxide synthase inhibitors |
| 03/21/2001 | EP1083925A1 Acrosomal sperm protein and uses thereof |
| 03/21/2001 | EP1083921A1 Novel leukotriene receptor antagonists and their uses |
| 03/21/2001 | EP1083917A1 Novel analgesic agents |
| 03/21/2001 | EP1083905A2 Selective estrogen receptor modulator in combination with dehydroepiandrosterone (dhea) or analogues |
| 03/21/2001 | EP1083904A2 Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 03/21/2001 | EP1083903A1 Bridged indenopyrrolocarbazoles |
| 03/21/2001 | EP1083893A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the d 1? receptors |
| 03/21/2001 | EP1083888A1 MULTIBINDING AGENTS THAT MODULATE PPARgamma AND RXR RECEPTORS |
| 03/21/2001 | CN1288383A St. John's wort and methyl donor composition and uses thereof |
| 03/21/2001 | CN1288007A 6-carbonyl-3-(4-[2-(pierid-1-yl)elhoyl]phenoxy)-2(4-methoxylphenyl) benzo[b]thiophene salt crystal |
| 03/21/2001 | CN1287841A 'Anshenwan' for treating male infertility |
| 03/21/2001 | CN1287840A Medicine for treating gynecological chronic inflammation and its prepn. method |
| 03/21/2001 | CN1287837A Forest forg's sprawn and its application |
| 03/21/2001 | CN1063437C Fluorophenyl sbstd. alkenylc arboxylic acid guanidine its preparation method applied as medicine and diagnosis agent and medicine containing the compound |
| 03/21/2001 | CN1063436C Fluoroalkyl-acyclic alkenyl substituted benzoylguanidines prepn. method and usage thereof |